本页面由Tiger Trade Technology Pte. Ltd.提供服务

Monopar Therapeutics

109.87
+4.173.95%
盘后109.870.00000.00%19:53 EDT
成交量:22.98万
成交额:2,470.91万
市值:7.34亿
市盈率:-57.18
高:110.23
开:105.47
低:103.00
收:105.70
52周最高:116.64
52周最低:29.18
股本:668.26万
流通股本:411.75万
量比:0.84
换手率:5.58%
股息:- -
股息率:- -
每股收益(TTM):-1.9216
每股收益(LYR):-1.8509
净资产收益率:-15.86%
总资产收益率:-12.11%
市净率:5.42
市盈率(LYR):-59.36

数据加载中...

公司资料

公司名字:
Monopar Therapeutics
交易所:
NASDAQ
成立时间:
2014
员工人数:
22
公司地址:
1000 Skokie Boulevard,Suite 350,Wilmette,Illinois,United States
邮编:
60091
电话:
传真:
- -
简介:
Monopar Therapeutics Inc.成立于2014年12月5日。该公司是一家临床阶段的生物制药公司,开发威尔逊病的创新治疗方法和肿瘤学的新型放射性药物。

董事

名称
职位
Chandler D. Robinson
Chief Executive Officer, Director
Christopher M. Starr
Executive Chairman, Director
Andrew P. Mazar
Executive Vice President of Research and Development, Chief Scientific Officer, Director
Arthur J. Klausner
Director
Michael J. Brown
Director
Raymond W. Anderson
Director

股东

名称
职位
Chandler D. Robinson
Chief Executive Officer, Director
Kim R. Tsuchimoto
Chief Financial Officer, Secretary and Treasurer
Andrew P. Mazar
Executive Vice President of Research and Development, Chief Scientific Officer, Director
Christopher M. Starr
Executive Chairman, Director
Patrice Rioux
Acting Chief Medical Officer